retatrutide parkinson clinical trial parkinson's disease What has the Parkinson's clinical trial landscape looked like in the Parkinson's drug pipeline evolution and

Current research is focused on validating these predictive models in diverse populations and expanding biomarker panels to include polygenic risk scores and proteomic signatures

Here is what the company's own published materials reveal

Where the real concern should be: There ARE bad practices in GLP-1 prescribing, little to zero medical oversight and the grey market for GLP-1s, including suspect sources and counterfeit medications

Compared to basal-bolus insulin therapy, insulin/GLP-1 drugs offer a simple and safe approach to managing titration, Billings said

Over the past few years, GLP-1 medications for weight loss such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have surged in popularity, including among older adults